Copyright: ©Author(s) 2026.
World J Gastroenterol. Nov 7, 2026; 32(41): 121890
Published online Nov 7, 2026. doi: 10.3748/wjg.121890
Published online Nov 7, 2026. doi: 10.3748/wjg.121890
Table 1 The correlation between expression of hnRNPA2B1 and clinicopathologic characteristics of 30 esophageal squamous cell carcinoma patients
| Variables | HnRNPA2B1 expression | P1 value | |
| High | Low | ||
| Age (years) | |||
| < 60 | 11 | 7 | 1.000 |
| ≥ 60 | 8 | 4 | |
| Gender | |||
| Female | 4 | 3 | 1.000 |
| Male | 15 | 8 | |
| Grade | |||
| I | 6 | 9 | 0.021 |
| II-III | 13 | 2 | |
| Tumor size (cm) | |||
| < 5 | 16 | 6 | 0.104 |
| ≥ 5 | 3 | 5 | |
| Lymph node metastasis | |||
| N0 | 11 | 5 | 0.412 |
| N+ | 4 | 4 | |
| COX-2 expression | |||
| High | 18 | 5 | 0.004 |
| Low | 1 | 6 | |
- Citation: Lu JQ, Fang XF, Guo XX, Liu M, Lin JH, Zheng HL, Zhong CM, Lin QY, Huang XY, Wang XZ, Tian H, Que JW, Chen FL, Zheng BY. Epitranscriptomic regulation of the COX-2/PGE2 axis by hnRNPA2B1 promotes esophageal squamous cell carcinoma progression. World J Gastroenterol 2026; 32(41): 121890
- URL: https://www.wjgnet.com/1007-9327/full/v32/i41/121890.htm
- DOI: https://dx.doi.org/10.3748/wjg.121890